2 Einträge gefunden

1. Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis

   1. Gordon, K B
   2. Lebwohl, M
   3. Papp, K A
   4. Bachelez, H
   5. Wu, J J
   6. Langley, R G
   7. Blauvelt, A

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients

   1. Wu, J J
   2. Lin, C
   3. Sun, L
   4. Goldblum, O
   5. Zbrozek, A
   6. Burge, R
   7. Augustin, M

   2019 - Forschungsinformationssystem des UKE